Severe tricuspid regurgitation: aetiology, patient characteristics, and treatment: a multicentre, prospective registry
ESC Heart Failure · 04.07.2026 · 13 (4)
DOI: 10.1093/eschf/xvag190 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift ESC Heart Failure, online erschienen am 16.07.2026. Verfasst von Agnieszka Kapłon-Cieślicka und 54 weiteren Autor:innen. Beteiligte Einrichtung: 1st Chair and Department of Cardiology, Medical University of Warsaw, Banacha 1A, Warsaw 02-097, Poland. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Registries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Polish Cardiac Society, PCS Scientific Platform.
Abstract (Originalsprache)
Background and Aims Severe tricuspid regurgitation (TR) is associated with increased mortality and hospitalizations for heart failure (HF). Aetiologies of TR include: secondary (atrial or ventricular), primary and cardiac implantable electronic device (CIED)-related. The aim of the study was to assess the prevalence of different TR aetiologies, as well as characteristics and treatment of patients with severe TR in a real-life setting.
Methods
This was a prospective, observational study of patients with severe TR, conducted in 18 cardiology centres. Consecutive adult patients with severe TR were included, regardless of the presence of TR symptoms and the cause of hospital admission.
Results
A total of 1295 patients with severe TR were enrolled (median age 76 years, 53% women). The most common reason for admission was HF decompensation (40%). Single TR aetiology was identified in 79% patients. The most frequent overlap between aetiologies included secondary ventricular and atrial TR, and was found in 11% of patients. The most common TR aetiology was secondary atrial (37%), followed by secondary ventricular (25%). Primary and CIED-related TR accounted for 10% and 15%, respectively. In 2.4% TR aetiology was not determined. Patients with secondary atrial and CIED-related TR were the oldest (79 and 78 years, respectively), and those with primary TR the youngest (68 years). Patients with CIED-related and secondary ventricular TR were more often hospitalized for HF decompensation, had more advanced HF symptoms, worse left- and right-ventricular function, worse kidney and liver function, and higher in-hospital mortality. Only 40% of patients underwent evaluation by the Heart Team and 21% were qualified for TR interventions.
Conclusions
In real life, unequivocal identification of TR aetiology remains challenging. Secondary atrial TR is the most common aetiology. There are significant differences in characteristics and outcomes depending on TR aetiology. Too few patients with severe TR undergo evaluation by the Heart Team.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1st Chair and Department of Cardiology, Medical University of Warsaw, Banacha 1A, Warsaw 02-097, Poland.
- Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, Institute of Cardiology, St. John Paul II Hospital, Kraków, Poland.
- Department of Nuclear Medicine, St. John Paul II Hospital, Kraków, Poland.
- Pulmonary Circulation Centre Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, Kraków, Poland.
- Department of Cardiology and Cardiovascular Interventions, University Hospital, Kraków, Poland.
- Department of Anatomy, Jagiellonian University Medical College, Kraków, Poland.
ORCID-Profile: Adam Piasecki, Katarzyna Holcman, Andrzej Gackowski, Katarzyna Mizia-Stec, Piotr Pruszczyk, Adam Rdzanek
Förderung
- Polish Cardiac Society
- PCS Scientific Platform
Zitieren
APA
Kapłon-Cieślicka, A., Piasecki, A., Semczuk-Kaczmarek, K., Holcman, K., Szczepara, S., Kopeć, G., Krawczyk-Ożóg, A., Rajtar-Salwa, R., Sorysz, D., Kamiński, K., Knapp, M., Stelmaszek, S., Królikowska, M., Furman-Niedziejko, A., Gackowski, A., Polańska-Szczap, A., Tuskowska, G., Koziński, M., Tomaszuk-Kazberuk, A., …, & Rdzanek, A. (2026). Severe tricuspid regurgitation: aetiology, patient characteristics, and treatment: a multicentre, prospective registry. ESC Heart Failure, 13(4). https://doi.org/10.1093/eschf/xvag190
Vancouver
Kapłon-Cieślicka A, Piasecki A, Semczuk-Kaczmarek K, Holcman K, Szczepara S, Kopeć G, et al. Severe tricuspid regurgitation: aetiology, patient characteristics, and treatment: a multicentre, prospective registry. ESC Heart Failure. 2026;13(4). doi:10.1093/eschf/xvag190
BibTeX
@article{KaponCielicka2026,
author = {Kapłon-Cieślicka, Agnieszka and Piasecki, Adam and Semczuk-Kaczmarek, Karolina and Holcman, Katarzyna and Szczepara, Sylwia and Kopeć, Grzegorz and Krawczyk-Ożóg, Agata and Rajtar-Salwa, Renata and Sorysz, Danuta and Kamiński, Karol and Knapp, Małgorzata and Stelmaszek, Sebastian and Królikowska, Maria and Furman-Niedziejko, Anna and Gackowski, Andrzej and Polańska-Szczap, Agata and Tuskowska, Grażyna and Koziński, Marek and Tomaszuk-Kazberuk, Anna and Dudzińska, Kinga and Muszyński, Paweł and Daniłowicz-Szymanowicz, Ludmiła and Kaufmann, Damian and Szwoch, Małgorzata and Uziębło-Życzkowska, Beata and Maciorowska, Małgorzata and Krzesiński, Paweł and Markiewicz, Agata and Bartczak-Rutkowska, Agnieszka and Grygier, Marek and Kijewski, Bartosz and Błaszczyk, Robert and Kondracki, Bartosz and Rudziński, Piotr Nikodem and Demkow, Marcin and Dębski, Mariusz and Tokarek, Tomasz and Dykla, Dominika and Zeliaś, Aleksander and Gałąska, Rafał and Fijałkowski, Marcin and Niemiec, Małgorzata and Mizia-Stec, Katarzyna and Kurnicka, Katarzyna and Pruszczyk, Piotr and Pręgowski, Jerzy and Skowroński, Jarosław and Bielecka-Dąbrowa, Agata and Kupczyńska, Karolina and Pędzich, Ewa and Ostrowska, Ewa and Tomaniak, Mariusz and Grabowski, Marcin and Scisło, Piotr and Rdzanek, Adam},
title = {Severe tricuspid regurgitation: aetiology, patient characteristics, and treatment: a multicentre, prospective registry},
journal = {ESC Heart Failure},
year = {2026},
volume = {13},
number = {4},
doi = {10.1093/eschf/xvag190}
}
EUVIMED